The majority of strokes could be prevented, according to new guidelines aimed at helping people and their doctors do just ...

Longevity specialist Dr Stuart Jay Olshansky on why he’s bet against the human condition, and the consequences of interfering ...

The transformative takeover by Mars Inc. has been overwhelmingly approved, marking a pivotal moment in the snack industry.

Closer to home, French parliamentary elections led to a temporary rise ... Its obesity blockbuster drug Wegovy experienced surging demand globally, particularly so in the US, with sales increasing by ...

He argues – as he always has – that if we don’t find a way to truly slow ageing, then no matter what biohackers might claim ...

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and ...

Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...

into the mix. In a retatrutide study with 338 people last year, patients lost up to about 24% of their weight at higher doses ...

Our list of online Wegovy providers includes reputable brands with licensed healthcare providers who can support you on your ...

Wegovy Q3 sales total $2.5 bln Beat forecast but group sales weaker than expected Results soothe investor worries over slowing obesity drug demand Shares rose nearly 9%, but later reversed course ...

Dr. Reed specializes in IV medications. Wegovy (semaglutide) is an injectable medication that is FDA-approved for obesity management and weight loss in people over age 12. Your healthcare provider ...